1. Home
  2. CAL vs DVAX Comparison

CAL vs DVAX Comparison

Compare CAL & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAL
  • DVAX
  • Stock Information
  • Founded
  • CAL 1878
  • DVAX 1996
  • Country
  • CAL United States
  • DVAX United States
  • Employees
  • CAL N/A
  • DVAX N/A
  • Industry
  • CAL Shoe Manufacturing
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAL Consumer Discretionary
  • DVAX Health Care
  • Exchange
  • CAL Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • CAL 1.5B
  • DVAX 1.5B
  • IPO Year
  • CAL N/A
  • DVAX 2004
  • Fundamental
  • Price
  • CAL $32.51
  • DVAX $11.02
  • Analyst Decision
  • CAL Hold
  • DVAX Buy
  • Analyst Count
  • CAL 2
  • DVAX 3
  • Target Price
  • CAL $32.50
  • DVAX $23.67
  • AVG Volume (30 Days)
  • CAL 936.4K
  • DVAX 1.7M
  • Earning Date
  • CAL 11-19-2024
  • DVAX 10-31-2024
  • Dividend Yield
  • CAL 0.86%
  • DVAX N/A
  • EPS Growth
  • CAL 12.22
  • DVAX N/A
  • EPS
  • CAL 4.63
  • DVAX 0.13
  • Revenue
  • CAL $2,801,542,000.00
  • DVAX $249,694,000.00
  • Revenue This Year
  • CAL N/A
  • DVAX $23.66
  • Revenue Next Year
  • CAL $3.30
  • DVAX $19.46
  • P/E Ratio
  • CAL $7.04
  • DVAX $86.59
  • Revenue Growth
  • CAL N/A
  • DVAX N/A
  • 52 Week Low
  • CAL $24.71
  • DVAX $9.74
  • 52 Week High
  • CAL $44.51
  • DVAX $15.15
  • Technical
  • Relative Strength Index (RSI)
  • CAL 40.83
  • DVAX 47.74
  • Support Level
  • CAL $31.08
  • DVAX $10.65
  • Resistance Level
  • CAL $33.59
  • DVAX $11.58
  • Average True Range (ATR)
  • CAL 1.06
  • DVAX 0.32
  • MACD
  • CAL 0.03
  • DVAX 0.01
  • Stochastic Oscillator
  • CAL 41.45
  • DVAX 39.79

About CAL Caleres Inc.

Caleres Inc is a footwear retailer in the United States. The Company's business are organized into two reportable segments are famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of famous Footwear retail stores, famousfootwear.com and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a carefully cultivated portfolio of top brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear to online retailers, national chains, department stores, mass merchandisers and independent retailers, as well as Company owned famous Footwear, Sam Edelman, Naturalizer and Allen Edmonds stores and e-commerce businesses.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: